FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2986104336> ?p ?o ?g. }

• W2986104336 abstract "Abstract Therapeutically targeting receptor tyrosine kinases has proven to be paramount to overcoming chemotherapy resistance in several cancer indications, improving patient outcomes. Insulin-Like Growth Factor Receptor 1 (IGF-1R) and Epidermal Growth Factor Receptor 3 (ErbB3) have been implicated as two such drivers of resistance, however their simultaneous role in ovarian cancer chemotherapy resistance remains poorly elucidated. The aim of this work is to determine the effects of dual IGF-1R/ErbB3 inhibition on ovarian cancer cell signaling, growth, and in vivo efficacy. Assessment of in vitro chemotherapy response across a panel of ovarian cancer cell lines revealed that increased IGF-1R cell surface expression correlates with decreased sensitivity to chemotherapy, and that growth induced by IGF-1R and ErbB3 ligands is blocked by the tetravalent bispecific antibody targeting IGF-1R and ErbB3, istiratumab. In vitro chemotherapy treatment increased ovarian cancer cell line capacity to activate prosurvival PI3K signaling in response to ligand, which could be prevented with istiratumab treatment. Furthermore, in vivo efficacy of standard of care chemotherapies using a xenograft model of ovarian cancer was potentiated with istiratumab. Our results suggest a role for IGF-1R and ErbB3 in driving chemotherapy resistance of ovarian cancer." @default.
• W2986104336 created "2019-11-22" @default.
• W2986104336 creator A5007255501 @default.
• W2986104336 creator A5008160506 @default.
• W2986104336 creator A5017341589 @default.
• W2986104336 creator A5020173185 @default.
• W2986104336 creator A5025211692 @default.
• W2986104336 creator A5032545251 @default.
• W2986104336 creator A5033909913 @default.
• W2986104336 creator A5041658971 @default.
• W2986104336 creator A5069091223 @default.
• W2986104336 creator A5072389805 @default.
• W2986104336 creator A5074208999 @default.
• W2986104336 creator A5074475804 @default.
• W2986104336 creator A5087864188 @default.
• W2986104336 date "2019-11-14" @default.
• W2986104336 modified "2023-10-18" @default.
• W2986104336 title "Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer" @default.
• W2986104336 cites W1968807523 @default.
• W2986104336 cites W1978343870 @default.
• W2986104336 cites W1978387360 @default.
• W2986104336 cites W1979056373 @default.
• W2986104336 cites W1984469163 @default.
• W2986104336 cites W1997579117 @default.
• W2986104336 cites W2006827588 @default.
• W2986104336 cites W2017081079 @default.
• W2986104336 cites W2025715007 @default.
• W2986104336 cites W2036253797 @default.
• W2986104336 cites W2037690883 @default.
• W2986104336 cites W2052812818 @default.
• W2986104336 cites W2061205910 @default.
• W2986104336 cites W2094145539 @default.
• W2986104336 cites W2109699928 @default.
• W2986104336 cites W2120878737 @default.
• W2986104336 cites W2127812467 @default.
• W2986104336 cites W2144230749 @default.
• W2986104336 cites W2152295037 @default.
• W2986104336 cites W2152419134 @default.
• W2986104336 cites W2169961966 @default.
• W2986104336 cites W2269768516 @default.
• W2986104336 cites W2508062996 @default.
• W2986104336 cites W2543492861 @default.
• W2986104336 cites W2569188130 @default.
• W2986104336 cites W2600744694 @default.
• W2986104336 cites W2620174055 @default.
• W2986104336 cites W2751739209 @default.
• W2986104336 cites W2789824316 @default.
• W2986104336 cites W2794723335 @default.
• W2986104336 cites W2807649309 @default.
• W2986104336 doi "https://doi.org/10.1038/s41598-019-53322-y" @default.
• W2986104336 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6856132" @default.
• W2986104336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31728045" @default.
• W2986104336 hasPublicationYear "2019" @default.
• W2986104336 type Work @default.
• W2986104336 sameAs 2986104336 @default.
• W2986104336 citedByCount "13" @default.
• W2986104336 countsByYear W29861043362020 @default.
• W2986104336 countsByYear W29861043362021 @default.
• W2986104336 countsByYear W29861043362022 @default.
• W2986104336 countsByYear W29861043362023 @default.
• W2986104336 crossrefType "journal-article" @default.
• W2986104336 hasAuthorship W2986104336A5007255501 @default.
• W2986104336 hasAuthorship W2986104336A5008160506 @default.
• W2986104336 hasAuthorship W2986104336A5017341589 @default.
• W2986104336 hasAuthorship W2986104336A5020173185 @default.
• W2986104336 hasAuthorship W2986104336A5025211692 @default.
• W2986104336 hasAuthorship W2986104336A5032545251 @default.
• W2986104336 hasAuthorship W2986104336A5033909913 @default.
• W2986104336 hasAuthorship W2986104336A5041658971 @default.
• W2986104336 hasAuthorship W2986104336A5069091223 @default.
• W2986104336 hasAuthorship W2986104336A5072389805 @default.
• W2986104336 hasAuthorship W2986104336A5074208999 @default.
• W2986104336 hasAuthorship W2986104336A5074475804 @default.
• W2986104336 hasAuthorship W2986104336A5087864188 @default.
• W2986104336 hasBestOaLocation W29861043361 @default.
• W2986104336 hasConcept C115456853 @default.
• W2986104336 hasConcept C121608353 @default.
• W2986104336 hasConcept C126322002 @default.
• W2986104336 hasConcept C143998085 @default.
• W2986104336 hasConcept C150903083 @default.
• W2986104336 hasConcept C207001950 @default.
• W2986104336 hasConcept C2776694085 @default.
• W2986104336 hasConcept C2779438470 @default.
• W2986104336 hasConcept C2780427987 @default.
• W2986104336 hasConcept C502942594 @default.
• W2986104336 hasConcept C62478195 @default.
• W2986104336 hasConcept C71924100 @default.
• W2986104336 hasConcept C86554907 @default.
• W2986104336 hasConcept C86803240 @default.
• W2986104336 hasConcept C95444343 @default.
• W2986104336 hasConcept C98274493 @default.
• W2986104336 hasConceptScore W2986104336C115456853 @default.
• W2986104336 hasConceptScore W2986104336C121608353 @default.
• W2986104336 hasConceptScore W2986104336C126322002 @default.
• W2986104336 hasConceptScore W2986104336C143998085 @default.
• W2986104336 hasConceptScore W2986104336C150903083 @default.
• W2986104336 hasConceptScore W2986104336C207001950 @default.
• W2986104336 hasConceptScore W2986104336C2776694085 @default.
• W2986104336 hasConceptScore W2986104336C2779438470 @default.
• W2986104336 hasConceptScore W2986104336C2780427987 @default.

• next